TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Tuberculosis
Research findings from L. Jugheli et al update understanding of tuberculosis
June 10th, 2008
According to a study from Antwerp, Belgium, "Penitentiary system of Georgia. To determine the prevalence of resistance to second-line drugs among prisoners with pulmonary tuberculosis (PTB)." "Retrospective evaluation of resistance to second-line drugs in tuberculosis (TB) patients treated from 2001 to 2003. The overall observed prevalence of multidrug-resistant TB (MDR-TB) was 14.4% (39/270). The lowest resistance was found for ofloxacin (OFX), which was 2.2% (6/270) overall and 5.1% (2/39) among MDR patients. Isolates from four non-MDR patients who had never received anti-tuberculosis treatment were found to be resistant to OFX. Resistance to kanamycin and capreomycin...
Source: TB & Outbreaks Week (2008-06-10)
|
